Form 4: Alto Neuroscience CFO Reports Stock Transaction
Insider Transaction (Form 4)
Nicholas Conrad Smith, PRESIDENT AND CFO of Alto Neuroscience, Inc., reported multiple transactions in common stock on October 2, 2026.
Summary
- Option exercise/conversion: acquired 55,000 Common Stock at $2.32 ($127,600) on October 2, 2026; holds 79,060 after (Direct).
- Option exercise/conversion: disposed of 55,000 Employee Stock Option (Right to Buy) on October 2, 2026; holds 57,405 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Nicholas Conrad Smith — Officer (PRESIDENT AND CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Option exercise/conversion | Common Stock | 55,000 | $2 | $127.6K | 79,060 |
| 2026-10-02 | Option exercise/conversion | Employee Stock Option (Right to Buy) | 55,000 | — | — | 57,405 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Option exercise/conversion (55,000 shares) |
| 2026-10-02 | Option exercise/conversion (55,000 shares) |
Keywords
insider transaction, Form 4, ANRO, Alto Neuroscience, Inc., neutral, Nicholas Conrad Smith
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.